// CATALOG · 42 COMPOUNDS · ALL LOT-VERIFIED
A 39–amino-acid dual agonist hitting both GIP and GLP-1 pathways. Synthesized for sustained appetite suppression, glucose control, and significant weight loss in clinical populations.
Investigational triple agonist — the next-generation follow-up to tirzepatide, adding glucagon receptor activity.
The well-studied GLP-1 analog at the foundation of modern weight-management therapy.
Nicotinamide-N-methyltransferase inhibitor studied for adipocyte metabolism and mitochondrial support.
Estrogen-related receptor agonist studied as an exercise-mimetic pathway.
Cofactor for long-chain fatty-acid transport into the mitochondria for β-oxidation.
A stable gastric juice-derived pentadecapeptide studied for soft-tissue repair and gut integrity.
Actin-binding fragment studied for cellular migration, angiogenesis, and soft-tissue recovery.
A copper-binding tripeptide studied for skin remodeling, collagen synthesis, and hair follicle signaling.
Lys-Pro-Val — a C-terminal α-MSH fragment studied for anti-inflammatory pathways.
A thymus-derived peptide studied for T-cell regulation and innate immune response.
A thymic peptide complex studied for immunomodulation and homeostatic signaling.
Full-length recombinant 191-amino-acid human growth hormone, pharmaceutical grade.
A 30-amino-acid GHRH analog with DAC for a ~6–8 day half-life. Sustained GH pulse elevation.
Also called Mod-GRF (1-29). Shorter half-life for natural pulsatile GH release.
Pentapeptide secretagogue with a clean selectivity profile — minimal cortisol or prolactin impact.
Truncated GHRH analog — 29 amino acids — for pulsatile GH release.
FDA-approved GHRH analog studied and indicated for visceral adiposity in specific populations.
Synthetic hexapeptide ghrelin mimetic studied for GH pulse amplification.
Second-generation GHRP hexapeptide — distinct receptor affinity profile vs GHRP-2.
The most potent of the classic GHRPs. Distinct cardiac receptor interactions in research.
C-terminal 16-aa fragment studied for lipolysis without affecting IGF-1 or insulin response.
Long Arg3 IGF-1 — extended half-life via reduced binding-protein affinity.
Pegylated IGF-1Ec splice variant — studied for satellite cell activation.
Ala-Glu-Asp-Gly — a synthetic tetrapeptide studied for telomerase activity.
The master cellular energy cofactor, central to sirtuin signaling and redox metabolism.
A cardiolipin-binding tetrapeptide studied for mitochondrial membrane stabilization.
A 16-aa peptide encoded in mitochondrial DNA, studied for AMPK signaling and metabolic regulation.
The body's principal endogenous antioxidant tripeptide — Glu-Cys-Gly.
A pineal-derived tripeptide studied for neuroprotection and cellular gene expression.
Russian-developed ACTH(4-7) analog studied for nootropic and neuroprotective effects.
A synthetic analog of the immunomodulatory peptide tuftsin, studied for anxiolytic effects.
A well-studied peptide complex used in neurological research and clinical practice abroad.
An oral-active small peptide studied for hepatocyte growth factor mimicry and synaptogenesis.
A nonapeptide studied for slow-wave sleep induction and stress response.
A melanocortin receptor agonist — FDA-approved (as bremelanotide) for hypoactive sexual desire.
The upstream regulator of the HPG axis, studied for reproductive and endocrine signaling.
A placental glycoprotein hormone — LH-mimetic used clinically for fertility and HPG support.
A mixed FSH/LH preparation used in fertility treatment protocols.
The 9-amino-acid neuropeptide studied for bonding, empathy, and stress response.
A selective α-MSH analog with a cleaner receptor profile than MT-2.
A cyclized α-MSH analog with broader melanocortin receptor activity including MC4R.
Intake takes about twelve minutes. A licensed MD reviews your submission within forty-eight hours.